Back to GetFilings.com



Table of Contents

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 10-Q
 
(Mark One)
x

  
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2002
 
 
¨

  
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from                      to                     
 
 
Commission File Number 000-26137
 

drugstore.com, inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
04-3416255
(State or other jurisdiction
of incorporation or organization)
 
(IRS Employer
Identification No.)
 
13920 Southeast Eastgate Way, Suite 300
Bellevue, Washington 98005
(Address of principal executive offices)
 
(425) 372-3200
(Registrant’s telephone number)
 

 
Check whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes    x    No    ¨
 
The number of shares of common stock, $.0001 par value, outstanding on August 12, 2002 was 68,135,865.
 


Table of Contents
 
DRUGSTORE.COM, INC.
 
CONTENTS
 
PART I—FINANCIAL INFORMATION
    
Item 1.
     
3
       
3
       
4
       
5
       
6
       
7
Item 2.
     
12
Item 3.
     
20
PART II—OTHER INFORMATION
    
Item 4.
     
20
Item 5.
     
20
Item 6.
     
20
       
21
 


Table of Contents
 
PART I—FINANCIAL INFORMATION
 
Item 1.
  
Financial Statements
 
DRUGSTORE.COM, INC.
 
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
 
    
June 30, 2002

    
December 30, 2001

 
    
(unaudited)
        
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
35,855
 
  
$
39,518
 
Marketable securities
  
 
30,077
 
  
 
39,238
 
Accounts receivable, net
  
 
13,429
 
  
 
10,171
 
Inventories
  
 
6,796
 
  
 
6,659
 
Prepaid marketing expenses
  
 
2,374
 
  
 
12,539
 
Other current assets
  
 
2,361
 
  
 
1,500
 
    


  


Total current assets
  
 
90,892
 
  
 
109,625
 
Fixed assets, net of accumulated depreciation of $26,957 and $23,492, respectively
  
 
19,228
 
  
 
23,948
 
Intangible assets, net
  
 
6,458
 
  
 
7,888
 
Goodwill, net
  
 
5,694
 
  
 
14,599
 
Prepaid marketing expenses
  
 
13,740
 
  
 
14,884
 
Deposits and other assets
  
 
378
 
  
 
354
 
    


  


Total assets
  
$
136,390
 
  
$
171,298
 
    


  


LIABILITIES AND STOCKHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable
  
$
23,039
 
  
$
20,309
 
Accrued compensation
  
 
2,526
 
  
 
2,608
 
Accrued marketing expenses
  
 
1,770
 
  
 
2,249
 
Other current liabilities
  
 
1,858
 
  
 
2,031
 
Current portion of capital lease obligations
  
 
1,027
 
  
 
1,612
 
    


  


Total current liabilities
  
 
30,220
 
  
 
28,809
 
Capital lease obligations, less current portion
  
 
294
 
  
 
638
 
Stockholders’ equity:
                 
Preferred stock, $.0001 par value:
                 
Authorized shares—10,000,000
                 
Issued and outstanding shares—None
  
 
—  
 
  
 
—  
 
Common stock, $.0001 par value, stated at amounts paid in:
                 
Authorized shares—250,000,000
                 
Issued and outstanding shares—68,014,301 and 66,731,818 as of June 30, 2002 and December 30, 2001, respectively
  
 
744,237
 
  
 
742,949
 
Deferred stock-based compensation
  
 
(1,197
)
  
 
(1,400
)
Accumulated deficit
  
 
(637,164
)
  
 
(599,698
)
    


  


Total stockholders’ equity
  
 
105,876
 
  
 
141,851
 
    


  


Total liabilities and stockholders’ equity
  
$
136,390
 
  
$
171,298
 
    


  


 
See accompanying notes to condensed consolidated financial statements.

3


Table of Contents
 
DRUGSTORE.COM, INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share and per share data)
(unaudited)
 
    
Three Months Ended

    
Six Months Ended

 
    
June 30, 2002

    
July 1, 2001

    
June 30, 2002

    
July 1, 2001

 
Net sales
  
$
47,615
 
  
$
34,035
 
  
$
91,551
 
  
$
66,804
 
Costs and expenses:
                                   
Cost of sales
  
 
38,350
 
  
 
28,494
 
  
 
73,782
 
  
 
56,260
 
Fulfillment and order processing(1)
  
 
6,497
 
  
 
6,915
 
  
 
13,167
 
  
 
14,683
 
Marketing and sales(2)
  
 
7,589
 
  
 
8,263
 
  
 
16,305
 
  
 
19,205
 
Technology and content(3)
  
 
3,280
 
  
 
4,845
 
  
 
6,810
 
  
 
10,560
 
General and administrative(4)
  
 
2,766
 
  
 
3,481
 
  
 
5,801
 
  
 
7,567
 
Impairment and restructuring charges
  
 
2,450
 
  
 
—  
 
  
 
2,450
 
  
 
7,294
 
Amortization of intangible assets
  
 
716
 
  
 
9,681
 
  
 
1,430
 
  
 
19,392
 
Amortization of stock-based compensation
  
 
340
 
  
 
1,572
 
  
 
1,107
 
  
 
4,449
 
    


  


  


  


Total costs and expenses
  
 
61,988
 
  
 
63,251
 
  
 
120,852
 
  
 
139,410
 
    


  


  


  


Operating loss
  
 
(14,373
)
  
 
(29,216
)
  
 
(29,301
)
  
 
(72,606
)
Interest income, net
  
 
389
 
  
 
1,199
 
  
 
740
 
  
 
2,933
 
    


  


  


  


Loss before cumulative effect of change in accounting principle
  
 
(13,984
)
  
 
(28,017
)
  
 
(28,561
)
  
 
(69,673
)
    


  


  


  


Cumulative effect of change in accounting principle
  
 
—  
 
  
 
(4,121
)
  
 
(8,905
)
  
 
(4,121
)
    


  


  


  


Net loss
  
$
(13,984
)
  
$
(32,138
)
  
$
(37,466
)
  
$
(73,794
)
    


  


  


  


Basic and diluted loss per share:
                                   
Loss before cumulative effect of change in accounting principle
  
$
(0.21
)
  
$
(0.43
)
  
$
(0.43
)
  
$
(1.06
)
Cumulative effect of change in accounting principle
  
 
—  
 
  
 
(0.06
)
  
 
(0.13
)
  
 
(0.06
)
    


  


  


  


    
$
(0.21
)
  
$
(0.49
)
  
$
(0.56
)
  
$
(1.12
)
    


  


  


  


Weighted average shares outstanding used to compute basic and diluted loss per share
  
 
67,590,381
 
  
 
65,940,203
 
  
 
67,318,948
 
  
 
65,705,611
 
    


  


  


  



(1)
 
Excludes amortization of stock-based compensation of $86 and $263 for the three and six months ended June 30, 2002, respectively, and $284 and $798 for the three and six months ended July 1, 2001, respectively.
(2)
 
Excludes amortization of stock-based compensation of $37 and $128 for the three and six months ended June 30, 2002, respectively, and $211 and $629 for the three and six months ended July 1, 2001, respectively.
(3)
 
Excludes amortization of stock-based compensation of $121 and $393 for the three and six months ended June 30, 2002, respectively, and $599 and $1,522 for the three and six months ended July 1, 2001, respectively.
(4)
 
Excludes amortization of stock-based compensation of $96 and $323 for the three and six months ended June 30, 2002, respectively, and $478 and $1,500 for the three and six months ended July 1, 2001, respectively.
 
See accompanying notes to condensed consolidated financial statements.

4


Table of Contents
 
DRUGSTORE.COM, INC.
 
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY
(in thousands, except share data)
(unaudited)
 
    
Common Stock

  
Deferred Stock-Based Compensation

    
Accumulated Deficit

    
Total

 
    
Shares

  
Amount

        
Balance at December 30, 2001
  
66,731,818
  
$
742,949
  
$
(1,400
)
  
$
(599,698
)
  
$
141,851
 
Exercise of stock options
  
995,464
  
 
349
  
 
—  
 
  
 
—  
 
  
 
349
 
Employee stock purchase plan
  
34,613
  
 
35
  
 
—  
 
  
 
—  
 
  
 
35
 
Issuance of common stock to settle fair market value guarantee
  
252,406
  
 
—  
  
 
—  
 
  
 
—  
 
  
 
—  
 
Deferred stock-based compensation, net of cancellations of $237
  
—  
  
 
904
  
 
(904
)
  
 
—  
 
  
 
—  
 
Amortization of stock-based compensation
  
—  
  
 
—  
  
 
1,107
 
  
 
—  
 
  
 
1,107
 
Net loss
  
—  
  
 
—  
  
 
—  
 
  
 
(37,466
)
  
 
(37,466
)